FDA News
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 49–60 of 391 articles
Amneal Romidepsin FDA Approval: B2B Analysis for BD Teams and Investors
FDA · 6 min
Dr. Sarah MitchellListeria Outbreak in Soft Cheese: FDA Investigation and Industry Impact
FDA · Listeria monocytogenes infections · 4 min
Dr. Sarah MitchellFDA Flavored Vape Ban: Youth Risk and Pharma Implications
FDA · 4 min
Dr. Sarah MitchellListeria Outbreaks 2026: FDA and CDC Soft Cheese Recall Analysis for Pharma
FDA · oncology · 6 min
Dr. Sarah Mitchell5 Notable Oncology FDA Approvals Granted in May: A B2B Analysis
FDA · oncology · 6 min
Dr. Sarah MitchellWeekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN
FDA · IgAN · 6 min
Dr. Sarah MitchellThe FDA Amendments Act And Drug Safety: Twenty Years Later
FDA · 5 min
Dr. Sarah MitchellFDA Issues June 2026 Guidance: Gene Therapy, Payor Comms, and CMC Flexibilities
FDA · 4 min
Dr. Sarah MitchellMay 2026 FDA Oncology Actions: 8 Approvals Reshape the Landscape
FDA · oncology · 5 min
Dr. Sarah MitchellFDA clears U.S. trial of MAIA lung cancer drug for third-line patients
FDA · lung cancer · 6 min
Dr. Sarah MitchellPharma bets on PD-1/VEGF bispecifics: Is lung cancer the wrong target?
FDA · non-small cell lung cancer · 5 min
Dr. Sarah MitchellSTAT+: What stripping civil service protections for thousands of federal workers will mean for HHS
FDA · 5 min
Dr. Sarah MitchellExplore intelligence